Clinical characteristics of malignant ovarian germ cell tumors

被引:0
|
作者
Zhang, Na [1 ]
Zhao, Jianguo [1 ]
Wang, Yue [2 ]
Qu, Pengpeng [1 ]
机构
[1] Tianjin Cent Hosp Gynecol Obstet, Dept Gynecol Oncol, 156 Nankai Three Rd, Tianjin 300100, Peoples R China
[2] Tianjin Cent Hosp Gynecol Obstet, Dept Obstet, Tianjin, Peoples R China
关键词
Malignant ovarian germ cell tumors; clinical characteristics; treatment; prognosis; RECURRENCE; FERTILITY; CANCER;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study was aimed to investigate the clinical characteristics, treatment and prognosis effect of malignant ovarian germ cell tumors (MOGCTs). A total of 39 patients with MOGCTs treated at Gynecology Obstetrics in Tianjin Central Hospital were enrolled from January 1999 to November 2009 in this study. All the patients underwent pathological examination and diagnosis was confirmed. We used univariate and multivariate logistic regression analysis to evaluate influencing factors, and Kaplan-Meier survival analysis and cox promotional hazard regression analysis were used to evaluate the survival rate. All of patients were followed up until November 30, 2014. Eight cases (20.5%) were dead. Six months were the shortest survival time and this patient with IV stage yolk sac tumor was ill-controlled after operation, progressing to death rapidly. In respect of surgical procedures, 5 cases in pregnant group underwent laparotomy and 3 cases underwent laparoscope; In unpregnancy group, 3 cases underwent laparotomy and 3 cases underwent laparoscope. There were no significant differences between two groups (P=1.000). Seven cases in pregnant group received chemotherapy and one didn't. In unpregnancy group, all the 6 cases received chemotherapy. The chemotherapy regimen was BEP (bleomycin, etoposide and cisplatine) and 4 courses were used. There were no significant differences between two groups (P=1.000). Kaplan-Meier survival analysis showed no significant differences in the impact of Federation of Gynecology and Obstetrics (FIGO) I-II staging on survival prognosis (P > 0.05), however, manifesting significant differences were found when compared to stage IV respectively (I vs IV, X-2=27.072, P < 0.001; II vs IV, X-2=6.983, P=0.008; III vs IV, X-2=10.671, P=0.001) and between stage I and stage III (X-2=4.965, P=0.026). The result of Cox regression identified only MOGCT histological type as a predictor of overall survival (OS, Wald=6.240, P=0.012). For pregnancy analysis, univariate logistic regression analysis showed that no significant difference was found between pregnancy group and non-pregnancy (Wald=2.410, P=0.121). A multivariate logistic regression analysis also showed no statistical differences between two groups. FIGO staging and MOGCT histological type are critical factors affecting the prognosis of the patients with MOGCTs. The pregnant outcome of the patients receiving chemotherapy is desirable, and there are no significant effects of age, surgical-pathological staging, MOGCT histological type, surgical procedures and tumor size on the pregnancy outcome.
引用
收藏
页码:10874 / 10881
页数:8
相关论文
共 50 条
  • [41] DNA content of ovarian immature teratomas and malignant germ cell tumors
    Baker, BA
    Frickey, L
    Yu, IT
    Hawkins, EP
    Cushing, B
    Perlman, EJ
    GYNECOLOGIC ONCOLOGY, 1998, 71 (01) : 14 - 18
  • [42] The influence of conservative surgical practices for malignant ovarian germ cell tumors
    Chan, John K.
    Tewari, Krishnansu S.
    Waller, Sarah
    Cheung, Michael K.
    Shin, Jacob Y.
    Osann, Kathryn
    Kapp, Daniel S.
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (02) : 111 - 116
  • [43] DNA copy number changes in malignant ovarian germ cell tumors
    Kraggerud, SM
    Szymanska, J
    Abeler, VM
    Kærn, J
    Eknæs, M
    Heim, S
    Teixeira, MR
    Tropé, CG
    Peltomäki, P
    Lothe, RA
    CANCER RESEARCH, 2000, 60 (11) : 3025 - 3030
  • [44] Ovarian germ cell tumors
    Weiss, J. M.
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2010, 8 (03): : 191 - 196
  • [45] Ovarian germ cell tumors
    Cusido, MT
    Jorda, B
    Gonzalez, J
    Garcia, A
    Xercavins, J
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (02) : 130 - 134
  • [46] Clinical outcome of lymphadenectomy in malignant ovarian germ cell tumors: a systematic review and meta-analysis
    Han, Ling
    Chen, Yali
    Liu, Yana
    Zheng, Ai
    Chen, Hengxi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (09): : 4458 - 4467
  • [47] Malignant Germ Cell Tumors of the Ovary Clinical and Imaging Features
    Rogers, Douglas
    Menias, Christine
    Shaaban, Akram
    RADIOLOGIC CLINICS OF NORTH AMERICA, 2023, 61 (04) : 579 - 594
  • [48] CLINICAL MANAGEMENT OF CHILDHOOD MALIGNANT GERM-CELL TUMORS
    ETCUBANAS, E
    THOMPSON, E
    JENKINS, J
    RAO, B
    BRODEUR, G
    HUSTU, O
    KUN, L
    GREEN, A
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (06): : 305 - 306
  • [49] Cancer Stem Cell Markers Are Differentially Expressed in Malignant Ovarian Germ Cell Tumors
    Davidson, Ben
    Solheim, Olesya
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2023, 42 (06) : 613 - 619
  • [50] Survival and reproductive function after treatment of malignant germ cell ovarian tumors
    Zanetta, G
    Bonazzi, C
    Cantù, MG
    Bini, S
    Locatelli, A
    Bratina, G
    Mangioni, C
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1015 - 1020